Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Modulation of Staphylococcus aureus Biofilm Formation by Subinhibitory Concentrations of Biogenic Silver Nanoparticles and Simvastatin

Version 1 : Received: 24 October 2023 / Approved: 25 October 2023 / Online: 25 October 2023 (08:37:04 CEST)

A peer-reviewed article of this Preprint also exists.

da Silva, A.C.F.; Roque, S.M.; Duarte, M.C.T.; Nakazato, G.; Durán, N.; Cogo-Müller, K. Modulation of Staphylococcus aureus Biofilm Formation through Subinhibitory Concentrations of Biogenic Silver Nanoparticles and Simvastatin. Future Pharmacol. 2024, 4, 3-17. da Silva, A.C.F.; Roque, S.M.; Duarte, M.C.T.; Nakazato, G.; Durán, N.; Cogo-Müller, K. Modulation of Staphylococcus aureus Biofilm Formation through Subinhibitory Concentrations of Biogenic Silver Nanoparticles and Simvastatin. Future Pharmacol. 2024, 4, 3-17.

Abstract

Staphylococcus aureus is a causative agent of nosocomial infections and its antibiotic-resistant strains are concerning. Solutions are being explored to improve the treatment of these infections, including repositioning drugs such as statins and using nanoparticles with antimicrobial properties. This study aimed to evaluate the antimicrobial effects of simvastatin (SIM) and biologically synthesized silver nanoparticles (bio-AgNPs) in isolate form and in combination by assays of minimum inhibitory concentration (MIC), an in vitro biofilm model, and the association of antimicrobials against clinical strains of S. aureus. Bio-AgNPs showed a 53.8 ± 1.23-nm mean diameter and standard deviation, a 0.23 polydispersity index, and a −25.66 ± 2.19-mV mean potential and standard deviation. Transmission electron microscopy confirmed the formation of nanoparticles and the presence of Ag0 and AgCl. S. aureus strains were sensitive to bio-AgNPs and SIM, showing 31.88-187.5 and 74.66-149.32 μM concentrations, respectively. Our association assay showed 2.0 fractional inhibitory concentration indices (i.e., indifferent for clinical strains) and 0.32 values for the standard ATCC 29213 strain (synergy). Our biofilm inhibition assays with isolated SIM and bio-AgNPs showed decreased biofilm formation from 4× to ⅛ MICs, showing no synergism in association. These findings evince that simvastatin and bio-AgNPs at subinhibitory concentrations can serve as antimicrobial agents against S. aureus biofilm.

Keywords

Staphylococcus areus; Statins; Biofilm; Antimicrobials; Silver nanoparticles

Subject

Medicine and Pharmacology, Pharmacy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.